INGRID BLAY CANTRELL: Open Payments
NPI 1851573349 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,196 in 82 payments from 18 companies in 2025. Trend: 2023 $149 · 2024 $471 · 2025 $2,196
Food & beverage: $2,096Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $653 |
| GlaxoSmithKline, LLC. | 23 | $289 |
| CSL Behring | 10 | $245 |
| Genentech USA, Inc. | 1 | $121 |
| Genentech, Inc. | 1 | $115 |
| BioCryst US Sales Co., LLC | 2 | $113 |
| Amgen Inc. | 6 | $110 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| GENZYME CORPORATION | 3 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $87 |
Products named: DUPIXENT, FASENRA, AIRSUPRA, Xolair, TEZSPIRE, TRELEGY ELLIPTA, ORLADEYO, NUCALA.
Industry payments across TN — which companies pay providers there.
